The change would disrupt longstanding payment arrangements in the pharmaceutical industry, which could lower patients’ costs but could also have unintended consequences.
USA: Trump Officials Move to Lower Drug Prices by Passing On Rebates to Patients
Reviewed by Shahid Karimi
on
February 01, 2019
Rating:
No comments: